A significant shift in Canadian drug policy has occurred, as the government permit the use of psilocybin hallucinogens for therapeutic applications. Previously, these substances were strictly restricted, but a mounting body of evidence suggests they potentially offer relief for psychological conditions like PTSD. This development represents a subst